Supplementation with quercetin markedly increases plasma quercetin concentration without effect on selected risk factors for heart disease in healthy subjects.

The purpose of this double-blind study was to investigate the influence of adding a quercetin-containing supplement to the diet on plasma quercetin status, serum/platelet fatty acid levels and risk factors for heart disease. Healthy men and women with cholesterol levels of 4.0-7.2 mmol/L, consumed four capsules daily of either a quercetin-containing supplement (1.0 g quercetin/d) or rice flour placebo for 28 d. Quercetin intakes were approximately 50-fold greater than the dietary intakes associated with lower coronary heart disease mortality on the basis of epidemiologic studies. Subjects consuming quercetin-containing capsules had plasma quercetin concentrations approximately 23-fold higher than those of subjects consuming the control capsules. Quercetin supplementation did not modify serum total, LDL or HDL cholesterol or triglyceride levels. There were also no alterations of other cardiovascular disease or thrombogenic risk factors, including platelet aggregation, platelet thromboxane B2 production, blood pressure or resting heart rate. Furthermore, there was no effect on the levels of (n-6) or (n-3) polyunsaturated fatty acids in serum or platelet phospholipids. In conclusion, supplementation with quercetin-containing capsules markedly enhanced the plasma quercetin concentration but had no effect on other cardiovascular or thrombogenic risk factors.

[1]  Samir Samman,et al.  Flavonoids—Chemistry, metabolism, cardioprotective effects, and dietary sources , 1996 .

[2]  H. Noteborn,et al.  Oral absorption and metabolism of quercetin and sugar-conjugated derivatives in specific transport systems. , 1997, Cancer letters.

[3]  A. Ferro-Luzzi,et al.  Application of a new high-performance liquid chromatographic method for measuring selected polyphenols in human plasma. , 1997, Journal of chromatography. B, Biomedical sciences and applications.

[4]  C. Teng,et al.  Inhibition of platelet aggregation by some flavonoids. , 1991, Thrombosis research.

[5]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[6]  K. Jenkins,et al.  Flavonoids increase tissue essential fatty acids in vitamin E-deficient chicks , 1995 .

[7]  G. Wong,et al.  Quercetin and rutin as inhibitors of azoxymethanol-induced colonic neoplasia. , 1991, Carcinogenesis.

[8]  Paul Knekt,et al.  Flavonoid intake and coronary mortality in Finland: a cohort study , 1996, BMJ.

[9]  E. Diamandis,et al.  The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease. , 1995, Clinica chimica acta; international journal of clinical chemistry.

[10]  Bruce Kinosian,et al.  Cholesterol and Coronary Heart Disease: Predicting Risks by Levels and Ratios , 1994, Annals of Internal Medicine.

[11]  P. Hollman,et al.  Consumption of quercetin and kaempferol in free-living subjects eating a variety of diets. , 1997, Cancer letters.

[12]  L. Larocca,et al.  Growth‐inhibitory effect of quercetin and presence of type‐II estrogen‐binding sites in human colon‐cancer cell lines and primary colorectal tumors , 1992, International journal of cancer.

[13]  E. Feskens,et al.  Dietary Flavonoids, Antioxidant Vitamins, and Incidence of Stroke: The Zutphen Study , 1996 .

[14]  P. Hollman,et al.  Bioavailability of the dietary antioxidant flavonol quercetin in man. , 1997, Cancer letters.

[15]  J. Kuhnau.  The flavonoids. A class of semi-essential food components: their role in human nutrition. , 1976 .

[16]  P. Naccache,et al.  The effects of quercetin, 1-tosylamido-2-phenylethyl chloromethyl ketone, cytochalasin A and nordihydroguaiaretic acid on lysosomal enzyme secretion, arachidonic acid metabolism and Ca2+ fluxes in rabbit neutrophils. , 1981, Journal of the Reticuloendothelial Society.

[17]  D Kromhout,et al.  Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. , 1995, Archives of internal medicine.

[18]  B. Holub,et al.  Supplementation with an algae source of docosahexaenoic acid increases (n-3) fatty acid status and alters selected risk factors for heart disease in vegetarian subjects. , 1996, The Journal of nutrition.

[19]  D Kromhout,et al.  Intake of potentially anticarcinogenic flavonoids and their determinants in adults in The Netherlands. , 1993, Nutrition and cancer.

[20]  Z. Qian,et al.  Effects of quercetin on platelet and reperfusion-induced arrhythmias in rats. , 1993, Zhongguo yao li xue bao = Acta pharmacologica Sinica.

[21]  J. Vinson,et al.  Plant Polyphenols Exhibit Lipoprotein-Bound Antioxidant Activity Using an in Vitro Oxidation Model for Heart Disease , 1995 .

[22]  P. Hollman,et al.  Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. , 1995, The American journal of clinical nutrition.

[23]  U. Justesen,et al.  Determination of plant polyphenols in Danish foodstuffs by HPLC-UV and LC-MS detection. , 1997, Cancer letters.

[24]  B Kinosian,et al.  Cholesterol and coronary heart disease: predicting risks in men by changes in levels and ratios. , 1995, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.

[25]  A. Ferro-Luzzi,et al.  Red wine, tea, and antioxidants , 1994, The Lancet.

[26]  B. Holub,et al.  Dietary docosahexaenoic acid as a source of eicosapentaenoic acid in vegetarians and omnivores , 1997, Lipids.

[27]  S. Maxwell,et al.  Red wine and antioxidant activity in serum , 1994, The Lancet.

[28]  R. Gryglewski,et al.  Flavonoids are scavengers of superoxide anions. , 1988, Biochemical pharmacology.

[29]  R. Gryglewski,et al.  On the mechanism of antithrombotic action of flavonoids. , 1987, Biochemical pharmacology.

[30]  J. Bai,et al.  Effects of quercetin on aggregation and intracellular free calcium of platelets. , 1995, Zhongguo yao li xue bao = Acta pharmacologica Sinica.

[31]  G. Born,et al.  Aggregation of Blood Platelets by Adenosine Diphosphate and its Reversal , 1962, Nature.

[32]  E. Feskens,et al.  Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study , 1993, The Lancet.

[33]  A. Nègre-Salvayre,et al.  Quercetin prevents the cytotoxicity of oxidized LDL on lymphoid cell lines. , 1992, Free radical biology & medicine.

[34]  J. Vinson,et al.  Plant Flavonoids, Especially Tea Flavonols, Are Powerful Antioxidants Using an in Vitro Oxidation Model for Heart Disease , 1995 .

[35]  U. Takahama.  Inhibition of lipoxygenase-dependent lipid peroxidation by quercetin: Mechanism of antioxidative function , 1985 .

[36]  L. Dragsted,et al.  Human absorption and excretion of flavonoids after broccoli consumption. , 1997, Cancer letters.

[37]  E. Middleton,et al.  Effects of flavonoids on immune and inflammatory cell functions. , 1992, Biochemical pharmacology.

[38]  R. Kirk.  Experimental Design: Procedures for the Behavioral Sciences , 1970 .

[39]  O. Texier,et al.  Quercetin metabolites in plasma of rats fed diets containing rutin or quercetin. , 1995, The Journal of nutrition.

[40]  C. Teng,et al.  Antiplatelet effects and vasorelaxing action of some constituents of Formosan plants. , 1993, Journal of natural products.

[41]  K. Igarashi,et al.  Effects of isorhamnetin, rhamnetin, and quercetin on the concentrations of cholesterol and lipoperoxide in the serum and liver and on the blood and liver antioxidative enzyme activities of rats. , 1995, Bioscience, biotechnology, and biochemistry.

[42]  W. Powell,et al.  Effects of a fish-oil and vegetable-oil formula on aggregation and ethanolamine-containing lysophospholipid generation in activated human platelets and on leukotriene production in stimulated neutrophils. , 1994, The American journal of clinical nutrition.

[43]  J. Cillard,et al.  Hydroxyl radical scavenging activity of flavonoids , 1987 .